At the recent Capital Markets Day CEO Trond Williksen outlined Benchmark’s strategy: to drive sustainability in aquaculture, improving product yield and quality for its customers, and at the same time to build Benchmark’s growth through planned phases of development in its three key business areas - Genetics, Advanced Nutrition and Health.
Restructured in 2020, the Group is now focused on consistent delivery, anchoring business area profitability and cashflow, and delivering on strategic programmes within a 2-5-year time frame. The direction of travel for Benchmark’s target markets in aquaculture remains positive. As the OECD1 notes “fish consumption is projected to keep rising at a faster rate than meat consumption over the next decade” and “Aquaculture is expected to drive production growth …to overtake capture fisheries production.” The Group outlined its growth pathway for each business area.
Our fair value for Benchmark is 63p/share.